CSIMarket



Express Scripts Holding Co.  (ESRX)
Other Ticker:  
 

Cumulative Express Scripts Holding Co.'s Leverage Ratio for Trailing Twelve Months Period

ESRX's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

ESRX Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
(Sep 30 2017)
III. Quarter
Y / Y Equity Growth 29.21 % 23.02 % 15.81 % 11.58 % 2.01 %
Y / Y Total Liabilities Growth 45.19 % 48 % 42.34 % 25.88 % -15.75 %
Leverage Ratio for Trailing Twelve Months Period 1.72 1.69 1.62 1.54 1.47
Total Ranking # 2159 # 2204 # 2262 # 2361 # 2170
Seq. Equity Growth 6.18 % 5.03 % 1.78 % 13.84 % 1.09 %
Seq. Total Liabilities Growth -1.07 % 1.28 % -3.3 % 49.85 % 0.85 %


Leverage Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Despite debt repayement of -1.07% in III. Quarter, Leverage Ratio for Trailing Twelve Months Period improved to 1.72, below Express Scripts Holding Co.'s average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Pharmacy Services & Retail Drugstore industry only one has achieved lower Leverage Ratio for Trailing Twelve Months Period. While Leverage Ratio for Trailing Twelve Months Period total ranking has improved so far to 2159, from total ranking in previous quarter at 2204.

What is Leverage Ratio?
Who are ESRX's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 2
Sector # 99
S&P 500 # 2078


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
6.83 2.73 1.35
(June 30, 2008)   (Dec 31 2013)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2018, within Pharmacy Services & Retail Drugstore Industry Leverage Ratio for Trailing Twelve Months Period
Adicet Bio Inc   2.67 
Cvs Health Corporation  1.82 
Express Scripts Holding Co.  1.64 
Luckwel Pharmaceuticals Inc   1.50 
Nu Skin Enterprises Inc   1.17 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

UHAL's Profile

Stock Price

UHAL's Financials

Business Description

Fundamentals

Charts & Quotes

UHAL's News

Suppliers

UHAL's Competitors

Customers & Markets

Economic Indicators

UHAL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071